Sepracor, Inc. (NASDAQ: SEPR), a research-based pharmaceutical company, has focused their efforts on treating and preventing human disease by discovering, developing and commercializing innovative pharmaceutical products designed to serve large and growing markets. The company’s drug development program has proven its success by yielding a portfolio of pharmaceutical products and candidates. The focus of the program is on treating respiratory and central nervous system (CNS) disorders. For further information, visit the Company’s web site at www.sepracor.com.
- 18 years ago
QualityStocks
Sepracor, Inc. (NASDAQ: SEPR)
Tags Rodman & Renshaw
Related Post
-
Mobilicom Ltd. (NASDAQ: MOB) Builds on $2.2 Million in Orders with Pipeline of Nine Tier-1 Design Wins Globally
Late last year, the Pentagon launched a $1 billion drone dominance program, with U.S. Secretary…
-
Gold Prices Rebound with Democratic Midterm Sweep In US
Disseminated on behalf of LaFleur Minerals Inc. and may include paid advertising. LaFleur Minerals Inc.…
-
Barry Ritholtz Joins Howard Lindzon to Open the Stocktoberfest 2026 Programming Day
The programming day of Stocktoberfest presented by Tradr ETFs opened on October 7 at City…